Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Two-pore domain potassium channel TWIK-1 (KCNK1) is a dimeric ion channel that plays a fundamental role in maintaining the resting membrane potential of cells by conducting potassium ions across the plasma membrane. Structurally unique among potassium channels, TWIK-1 consists of two subunits each containing four transmembrane domains and two pore-forming loops, which together form a single ion conduction pathway. The channel produces background leak currents that are quasi-instantaneous, noninactivating, and active across all membrane potentials, making it insensitive to classical potassium channel blockers. TWIK-1 is predominantly expressed in the central nervous system and has a well-established role in regulating cardiac rhythm and atrial size. The channel is regulated by diverse stimuli including protein kinase C activation, pH changes, and G-protein signaling. Dysregulation of TWIK-1 and related K2P channels has been associated with cardiac arrhythmias and heart failure, suggesting the channel represents a potential therapeutic target for cardiovascular diseases.
For drugs targeting K2P channels generally: Activation of channel opening leads to K+ efflux and hyperpolarization of the cell membrane, reducing cell excitability. Inhibition of channel activity increases membrane potential depolarization.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Two-pore domain potassium channel TWIK-1 (KCNK1) (TWIK-1, KCNK1).